|Articles|October 2, 2022
- Pharmaceutical Technology, October 2022
- Volume 46
- Issue 10
- Pages: 12
Next-Generation Synthetic Biology Workflow Platform
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.
The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.
Articles in this issue
about 3 years ago
Adopting Smart Development Strategiesabout 3 years ago
Reformulating Successabout 3 years ago
Analyzing Extractables and Leachables in Single-Use Systemsabout 3 years ago
Improving Sterility Using Blow-Fill-Seal Technologyabout 3 years ago
Electrochemistry for API Synthesisabout 3 years ago
Shining a Light on Lipid Nanoparticle Characterizationabout 3 years ago
The Future of Drug Delivery for Biopharmaceuticalsabout 3 years ago
The State of Contamination Controlabout 3 years ago
Biologic Standards in the Pharmacopoeias: An UpdateNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Comparator Selection & Supply: Best Practices for Clinical Success
5
